Evidence map›Paper›PMID 24203697›Full record

ArticleHuman molecular genetics2014

Novel mutations in Lrp6 orthologs in mouse and human neural tube defects affect a highly dosage-sensitive Wnt non-canonical planar cell polarity pathway.

Redouane Allache, Stéphanie Lachance, Marie Claude Guyot, Patrizia De Marco, Elisa Merello, Monica J Justice, Valeria Capra, Zoha Kibar

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. The involvement of the canonical Wnt-signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta-analysis.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2019
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Variants identified in PTK7 associated with neural tube defects.Molecular genetics & genomic medicine · 2019
    Article
  17. Article
  18. Article
  19. ZIC3 in Heterotaxy.Advances in experimental medicine and biology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Redouane AllacheCHU Sainte Justine Research Center and University of Montréal, Montréal, QC, Canada H3T 1C5.
Stéphanie Lachance
Marie Claude Guyot
Patrizia De Marco
Elisa Merello
Monica J Justice
Valeria Capra
Zoha Kibar
Istituto Giannina Gaslini · ITCentre Hospitalier Universitaire Sainte-Justine · CAUniversité de Montréal · CABaylor College of Medicine · US

Funding

MUTATIONS IN DEVELOPMENTAL PATHWAYS BY ENU MUTAGENESISU01HD039372 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI JUSTICE, MONICA JEAN · 2000 to 2005
$17.3M
Genetic analysis of mouse chromosome 11R01CA115503 · NCI · BAYLOR COLLEGE OF MEDICINE · PI JUSTICE, MONICA J. · 2006 to 2010
$2.6M
Canadian Institutes of Health ResearchNCI NIH HHS R01 CA115503NICHD NIH HHS U54 HD39372
6 · The paper itself

Abstract

Wnt signaling has been classified as canonical Wnt/β-catenin-dependent or non-canonical planar cell polarity (PCP) pathway. Misregulation of either pathway is linked mainly to cancer or neural tube defects (NTDs), respectively. Both pathways seem to antagonize each other, and recent studies have implicated a number of molecular switches that activate one pathway while simultaneously inhibiting the other thereby partially mediating this antagonism. The lipoprotein receptor-related protein Lrp6 is crucial for the activation of the Wnt/β-catenin pathway, but its function in Wnt/PCP signaling remains largely unknown. In this study, we investigate the role of Lrp6 as a molecular switch between both Wnt pathways in a novel ENU mouse mutant of Lrp6 (Skax26(m1Jus)) and in human NTDs. We demonstrate that Skax26(m1Jus) represents a hypermorphic allele of Lrp6 with increased Wnt canonical and abolished PCP-induced JNK activities. We also show that Lrp6(Skax26-Jus) genetically interacts with a PCP mutant (Vangl2(Lp)) where double heterozygotes showed an increased frequency of NTDs and defects in cochlear hair cells' polarity. Importantly, our study also demonstrates the association of rare and novel missense mutations in LRP6 that is an inhibitor rather than an activator of the PCP pathway with human NTDs. We show that three LRP6 mutations in NTDs led to a reduced Wnt canonical activity and enhanced PCP signaling. Our data confirm an inhibitory role of Lrp6 in PCP signaling in neurulation and indicate the importance of a tightly regulated and highly dosage-sensitive antagonism between both Wnt pathways in this process.

Indexed as

AdolescentAdultAnimalsBase Sequencebeta CateninCell PolarityChildCochleaFemaleGene Expression Regulation, DevelopmentalHumansIntracellular Signaling Peptides and ProteinsLow Density Lipoprotein Receptor-Related Protein-6MaleMembrane ProteinsMicebeta CateninIntracellular Signaling Peptides and ProteinsLow Density Lipoprotein Receptor-Related Protein-6LRP6 protein, humanMembrane ProteinsVANGL2 protein, humanWnt Proteins

Identifiers

PMID24203697
PMCPMC3943515
OpenAlexW2130354738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.